GT Biopharma, Inc.GTBPNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank29
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
Latest
$-34.45M
↑ 42% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-59.46M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-34.45M | -161.7% |
| 2024 | $-13.16M | -73.3% |
| 2023 | $-7.60M | +63.6% |
| 2022 | $-20.88M | +64.0% |
| 2021 | $-58.01M | -105.0% |
| 2020 | $-28.30M | +26.8% |
| 2019 | $-38.65M | +85.1% |
| 2018 | $-259.19M | -79.8% |
| 2017 | $-144.17M | -1576.0% |
| 2016 | $9.77M | - |